Qalam Health is a Canadian deep-technology medical innovation company developing real-time surgical intelligence tools to improve bone cancer surgery outcomes. Our mission is to empower surgeons with objective, data-driven insights during operations, enabling more precise tumor removal while preserving healthy tissue.
Cancer surgery remains a cornerstone of cancer treatment, yet surgeons often rely on visual inspection, tactile feedback, and preoperative imaging to determine bone tumor boundaries. Microscopic bone cancer cells can remain at the surgical margin and may only be detected after postoperative pathology analysis, sometimes leading to recurrence, additional surgeries, or long-term complications for patients.
To address this challenge, Qalam Health is developing an AI-enabled intraoperative diagnostic platform that provides real-time tissue characterization during surgery. The technology combines advanced imaging with machine learning to distinguish malignant from healthy bone tissue directly at the surgical site. By converting complex biophysical signals into interpretable information, Qalam enables surgeons to assess tumor margins intraoperatively without disrupting surgical workflow.
Built on strong clinical collaboration and translational research, the platform aims to advance surgical decision-making and reduce uncertainty in the operating room. Qalam Health ultimately aims to transform cancer surgery through intelligent, real-time diagnostic guidance.